“PAMKI Annual Conference 2025”
CarbGeM Inc. (Headquarters: Shibuya-ku, Tokyo; CEO: Masakazu Nakajima; hereinafter “CarbGeM”) participated in the “PAMKI Annual Conference 2025”, held from August 21 (Thu) to 23 (Sat), 2025, in Semarang, Indonesia, and delivered a 25-minute presentation in a sponsored symposium session.
The PAMKI Annual Conference is organized by the Indonesian Society of Clinical Microbiologists (PAMKI), which brings together clinical microbiologists from across Indonesia, and is recognized as one of the most prestigious academic conferences in the country.
The conference attracts a wide range of participants, including clinical microbiologists, infectious disease specialists, researchers, and government officials. Notably, representatives from the Indonesian Ministry of Health also attended, making the conference a forum where discussions directly influence infection control measures and healthcare policy.
CarbGeM delivered a lecture on the potential applications of AI in the field of clinical microbiology.
The presentation highlighted how CarbGeM’s technologies and products, including BiTTE® and CarbConnect®, can contribute to addressing antimicrobial resistance (AMR) and other healthcare challenges in Indonesia.
The presentation was met with strong interest in AI-driven clinical microbiology support, marking an important step toward strengthening collaborations with local partners and advancing healthcare digital transformation (DX) in Indonesia.
CarbGeM Inc. integrates cutting-edge AI and biotechnology to develop and provide DX and AI solutions primarily for the medical and life sciences fields. Through products such as AI-based research software, image analysis platforms, and automated testing devices, the company aims to enhance productivity in clinical and research settings and to help bridge the global gap in access to healthcare.
Official Website: https://carbgem.com/en/
